EPZ004777

Catalog #

27622

$205 *

Size: 5 mg

Qty

Bulk/Custom

Add to Favorites

*US Pricing only. For international pricing, please contact your local distributor.

●

Purchase

●

Description

EPZ004777 is a potent, selective DOT1L inhibitor with IC50 of 400 pM. EPZ004777 selectively kills a variety of MLL-rearranged leukemia cells, including an MLL-AF4 leukemia cell line MV4-11 and an MLL-AF9 leukemia cell line MOLM13.

●

Synonyms

1-[3-[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl-propan-2-ylamino]propyl]-3-(4-tert-butylphenyl)urea

●

Product Data Gallery

Product Info

Storage and Usage

Citations

Target(s)

Dot1L

Formula

C₂₈H₄₁N₇O₄

539.7 Da

Solubility

Soluble in DMSO

Biological Activity

EPZ004777 is a potent, selective DOT1L inhibitor with IC50 of 400 pM. EPZ004777 also exhibits anti-proliferative activity against both MLL-rearranged and non-rearranged human leukemia cell lines, including RS4;11 (IC50: 6.47 µM), SEM (IC50: 1.72 µM), MV4-11 (IC50: 0.17 µM), THP-1 (IC50: 3.36 µM), MOLM-13 (IC50: 0.72 µM), KOPN-8 (IC50: 0.62 µM), REH (IC50: 13.9 µM), Kasumi-1 (IC50: 32.99 µM) and 697 (IC50: 36.57 µM)

CAS Registry #

1338466-77-5

Background

EPZ004777 selectively inhibits cellular H3K79 methylation and inhibits expression of key MLL fusion target genes. EPZ004777 produces potent antitumor efficacy, and significantly increases median survival in a mouse xenograft model of MLL leukemia. Following DOT1L inhibition, EPZ004777 selectively inhibits proliferation of MLL-rearranged cell lines and MLL-AF9-transformed murine hematopoietic cells. In addition, EPZ004777 also induces differentiation and apoptosis in MLL-rearranged cells. DOT1L inhibition by EPZ004777 results in significantly decreased proliferation, decreased expression of MLL-AF6 target genes, and cell cycle arrest of MLL-AF6-transformed cells. EPZ004777 has also been found to selectively inhibit the proliferation of MLL-AF10 and CALM-AF10 transformed cells in a dose dependent manner (IC50: 0.1 µM to 1 µM), in which the mRNA expression levels of two hallmark leukemogenic genes (Hoxa9 and Meis1) are suppressed by EPZ004777 in a concentration dependent manner.

References

1. Yu W, Cet al. Nat Commun. 2012;3:1288.
2. Chen L,et al. 2013 Apr;27(4):813-22.

Skip to the end of the images gallery

Skip to the beginning of the images gallery

EPZ004777

PRODUCTS

SERVICES

RESOURCES

COMPANY